From Chronic Wounds to Scarring: The Growing Health Care Burden of Under- and Over-Healing Wounds
- PMID: 34521257
- PMCID: PMC9634983
- DOI: 10.1089/wound.2021.0039
From Chronic Wounds to Scarring: The Growing Health Care Burden of Under- and Over-Healing Wounds
Abstract
Significance: Wound healing is the largest medical market without an existing small molecule/drug treatment. Both "under-healing" (chronic wounds) and "over-healing" (scarring) cause a substantial biomedical burden and lifelong consequences for patients. These problems cost tens of billions of dollars per year in the United States alone, a number expected to grow as the population ages and the prevalence of common comorbidities (e.g., diabetes) rises. However, no therapies currently exist to produce the "ideal" healing outcome: efficient wound repair through regeneration of normal tissue. Recent Advances: Ongoing research continues to illuminate possible therapeutic avenues for wound healing. By identifying underlying mechanisms of wound repair-for instance, tissue mechanics' role in fibrosis or cell populations that modulate wound healing and scarring-novel molecular targets may be defined. This Advances in Wound Care Forum issue includes reviews of scientific literature and original research from the Hagey Laboratory for Pediatric Regenerative Medicine at Stanford and its alumni, including developing approaches for encouraging wound healing, minimizing fibrosis, and coaxing regeneration. Critical Issues: Wound healing problems reflect an enormous and rapidly expanding clinical burden. The issues of both under- and over-healing wound outcomes will continue to expand as their underlying causes (e.g., diabetes) grow. Targeted treatments are needed to enable wound repair with functional tissue restoration and decreased scarring. Future Directions: Basic scientists will continue to refine understanding of factors driving undesirable wound outcomes. These discoveries are beginning to be translated and, in the coming years, will hopefully form the foundation for antiscarring drugs and other wound therapeutics.
Keywords: chronic wounds; fibrosis; scarring; wound care; wound healing.
Conflict of interest statement
M.T.L. and G.G. are cofounders of, have equity positions in, and are on the Board of Directors of Neodyne Biosciences, Inc., which developed the embrace device. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in this article. The content of this article was written entirely by the authors listed. No ghostwriters were involved in the writing of this article.
References
-
- iGATE Research. Global Wound Care Market (by Product Type, Applications, Wound Type, Region and Company), Major Deals, Size, Share, Trends—Forecast to 2026. Delhi, India: iGate Research Pvt Ltd, 2019.
-
- Research PSIM. Scar Treatment Market Research Report: By Treatment Type (Topical, Surface, Laser, Injectable, Surgical), Scar Type (Atrophic and Acne Scar, Keloid and Hypertrophic Scar, Contracture Scar, Stretch Mark), End User (Home-Use, Hospitals, Dermatology Clinics)—Global Industry Analysis and Growth Forecast to 2030. Noida, India: Prescient & Strategic Intelligence, 2020.
-
- Nussbaum SR, Carter MJ, Fife CE, et al. . An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds. Value Health 2018;21:27–32. - PubMed
-
- Martinengo L, Olsson M, Bajpai R, et al. . Prevalence of chronic wounds in the general population: systematic review and meta-analysis of observational studies. Ann Epidemiol 2019;29:8–15. - PubMed
-
- Yao Z, Niu J, Cheng B. Prevalence of chronic skin wounds and their risk factors in an inpatient hospital setting in Northern China. Adv Skin Wound Care 2020;33:1–10. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
